236417-00-8

Basic information

• Product Name: 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-N'-(2-methanesulphonyl-ethyloxycarbonyl)benzamidine
• Synonyms: 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-N'-(2-methanesulphonyl-ethyloxycarbonyl)benzamidine
• CAS NO: 236417-00-8
• Molecular Weight: 705.813
• Mol File: 236417-00-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-N'-(2-methanesulphonyl-ethyloxycarbonyl)benzamidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-N'-(2-methanesulphonyl-ethyloxycarbonyl)benzamidine(236417-00-8)
• EPA Substance Registry System: 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-N'-(2-methanesulphonyl-ethyloxycarbonyl)benzamidine(236417-00-8)

Safety Data

• Hazardous Substances Data: 236417-00-8(Hazardous Substances Data)

Upstream product

• 236416-89-0 4-[(5-(N-ethoxycarbonylmethyl-quinolin-8-yl-sulphonylamino)-1-methyl-indol-2-yl)-methyl]-benzamidine-hydrochloride 
• 53298-30-9 2-(methylsulfonyl) ethyl-4-nitrophenyl carbonate 

Relevant articles and documents

Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals

The present invention relates to 5-membered heterocyclic condensed benzoderivatives of formula wherein Ra to Rc, A, X and Y are defined as in claim 1, the tautomers, stereoisomers, mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable properties. The compounds of the above formula I wherein Rc denotes a cyano group are valuable intermediates for preparing the other compounds of formula I, and the compounds of the above formula I wherein Rc denotes one of the following amidino groups and the tautomers and stereoisomers thereof have valuable pharmacological properties, particularly an antithrombotic activity.